Do women have more adverse drug reactions?

American Journal of Clinical Dermatology

Volumn 2, Issue 6, 2001, Pages 349-351

  Rademaker, Marius ^a  

^a WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; CHLORPROMAZINE; CONTRACEPTIVE AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; FLUSPIRILENE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PSYCHOTROPIC AGENT; TEMAZEPAM;

ALLERGIC REACTION; COMPETITIVE INHIBITION; DRUG SURVEILLANCE PROGRAM; HOSPITAL ADMISSION; HUMAN; LIVER CLEARANCE; ORAL CONTRACEPTION; POLYPHARMACY; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; SIDE EFFECT; T LYMPHOCYTE ACTIVATION;

EID: 0035666654     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200102060-00001     Document Type: Short Survey

References (2)

1. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999; 83: 665-700
2. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-84